Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015147
Filing Date
2024-11-12
Accepted
2024-11-12 07:02:26
Documents
64
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mist-20240930x10q.htm   iXBRL 10-Q 1547045
2 EX-10.1 mist-20240930xex10d1.htm EX-10.1 18416
3 EX-31.1 mist-20240930xex31d1.htm EX-31.1 12317
4 EX-31.2 mist-20240930xex31d2.htm EX-31.2 12468
5 EX-32.1 mist-20240930xex32d1.htm EX-32.1 9442
  Complete submission text file 0001558370-24-015147.txt   6428426

Data Files

Seq Description Document Type Size
6 EX-101.SCH mist-20240930.xsd EX-101.SCH 41861
7 EX-101.CAL mist-20240930_cal.xml EX-101.CAL 39710
8 EX-101.DEF mist-20240930_def.xml EX-101.DEF 165914
9 EX-101.LAB mist-20240930_lab.xml EX-101.LAB 351109
10 EX-101.PRE mist-20240930_pre.xml EX-101.PRE 280943
67 EXTRACTED XBRL INSTANCE DOCUMENT mist-20240930x10q_htm.xml XML 1214754
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38899 | Film No.: 241443197
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)